India
Deal paves way for Mankind to expand into the women’s health and fertility drug market.
1
Ant Group-owned payments firm 2C2P trims losses by 83% in 2023
2
SE Asian IPO fundraising plunges 60% in first half as Indonesia slumps
3
Thai auto sector reels under subsidies for Chinese EV makers
4
Shanghai launches $14b funds to ramp up IC, AI, biomedicine sectors
5
Private equity giant Apollo pumps $700 million into Sony Music
More Stories
L Catterton’s Asia chairman Chinta Bhagat steps down from role
Indosat’s potential sale of submarine cable and fibre assets may attract local bidders
SE Asian startups left thirsting as funding drought persists into Q2
Indonesia’s Volta plans to roll out EV scooters in more SE Asian markets
Grab calls off proposed acquisition of Singapore taxi operator Trans-cab
Rest of Asia
The Singapore-based investment firm holds around 18% stake in the Japanese film company.
World
The new fund is slated to target global investments in both private and public markets.
Greater China
The SWF still sees opportunities in China’s residential and commercial properties in major cities.
The deal values BusinessOn at $258 million.
The proceeds will be used to accelerate the development of Luye Pharma Group’s oncology drug business.
Singapore
Currently, the firm sees more interest emerging from the developed Asian markets, with SE Asia at a nascent stage.
Stonepeak, which has assets of around $71.2 billion, said it is offering NZ$1.70 per Arvida share.
It is also looking to raise a separate investment vehicle for the Japan market.
The predecessor fund, BPEA VIII, had raised over $11b in 2022.